Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Anika receives European marketing approval for osteoarthritis product

Sep. 27, 1996

U.S. patent covers hemopoietic regulator with potential in rheumatoid arthritis

Sep. 27, 1996

Monoclonal antibody effective in rheumatoid arthritis

Sep. 20, 1996

University of Kentucky's PC-16 for arthritis

Sep. 20, 1996

Progress in arthritis at Toyama

Sep. 13, 1996

Dual TNF production and PDE IV inhibitor from Pfizer

Sep. 13, 1996

Inhibitors of cytokine production reported by SmithKline Beecham

Sep. 13, 1996

Procter & Gamble discloses new matrix metalloproteinase inhibitors

Sep. 13, 1996

COX-2 inhibitors from Merck Frosst

Sep. 13, 1996

A new class of selective COX-2 inhibitors from Merck Frosst

Sep. 13, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...